$CNTX

$0.23 -$0.01 (2.17%) Close

$CNTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 91.9M shares outstanding

Who owns CNTX?

By type of holder

Institutions 68.3% Insiders 1.4% Everyone else 30.3%

Concentration Top 10 holders own 51.8%

MPM Bioimpact LLC 1.4% · Avidity Partners Management LP 5.4%

Institutional ownership

68.3%

-17.9 pts vs last qtr

Institutional holders

+18 vs last qtr

Net shares bought

−16.5M

by institutions in Q2 2026

New / sold out

36 / 18

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

BlackRock, Inc. +5.3M
Geode Capital Management, LLC +1.2M

Biggest sellers in Q2 2026

MPM Bioimpact LLC −9.4M
Avidity Partners Management LP −5.0M

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Context Therapeutics Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+496.2%

+144.17% a year

Each share's claim on the business

−83.2%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $3.25M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years15% 1–3 years56% Under 1 year29%

Quarterly turnover

28.7%

of institutional shares changed hands

Top 10 managers, median time held

2 years

Super Investors

Investment managers reporting CNTX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
MB MPM Bioimpact LLC	1.3M	1.41%	−9.4M (−87.8%)	2024	0.0%
Shares held by quarter Peak holding14.7M (Q4'24) Change over 8 quarters+1.3M Share of the company1.410% MPM Bioimpact LLC's full portfolio →
AP Avidity Partners Management LP	5.0M	5.44%	−5.0M (−50.0%)	2024	0.4%
Shares held by quarter Peak holding10.0M (Q1'26) Change over 8 quarters−2.4M Share of the company5.440% Avidity Partners Management LP's full portfolio →

MPM Bioimpact LLC

1.3M

% of company

1.41%

Change vs last qtr

−9.4M (−87.8%)

Held since

2024

Avidity Partners Management LP

5.0M

% of company

5.44%

Change vs last qtr

−5.0M (−50.0%)

Held since

2024

28 more super investors behind a free account

See every manager holding Context Therapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting CNTX on Form N-PORT; together they hold 11.8% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$1.56M	2.8M	3.06%	0.00%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$1.29M	2.3M	2.54%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$1.56M

% of company

3.06%

% of the fund

0.00%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$1.29M

% of company

2.54%

% of the fund

0.00%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Context Therapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
LM Lehr Martin A. Insider	1.1M	1.18%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company1.180% Lehr Martin A.'s insider activity →
LA Levit Alex C. Insider	82.0K	0.09%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.090% Levit Alex C.'s insider activity →

Lehr Martin A.

Insider

1.1M

% of company

1.18%

Change vs last qtr

—

Held since

—

Levit Alex C.

Insider

82.0K

% of company

0.09%

Change vs last qtr

—

Held since

—

1 more holders behind a free account

See every insider and 5%+ holder of Context Therapeutics Inc.

Comments